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Objective: To test a new system for the biotyping of Streptococcus mutans, based on the measurement of enzyme 
activity, and to investigate the relationship between biotype and in vitro susceptibility to seven clinically useful anti- 
biotics. 
Methods: In total, 160 oral isolates of S. mutanswere classified into different biotypes with the A P I N M  test for enzyme 
activity, excluding results that were positive or negative in >80% of the strains. The susceptibility of all 160 strains to 
amoxycillin, cefazolin, erythromycin, clindamycin, vancomycin, teicoplanin and imipenem was tested by dilution in a 
solid medium. Statistical analysis of susceptibility (mean minimum inhibitory concentrations (MICs)) was based on chi- 
squared tests. 
Results: Eight different biotypes (1-8) were identified on the basis of three kinds of enzyme activity: valine aryl amidase, 
acid phosphatase and a-galactosidase. Biotype 5 was found to be the most common. The mean MIC values showed 
strains belonging to biotype 4 to be the most susceptible to amoxycillin, cefazolin and erythromycin, whereas biotype 
1 was the least susceptible to teicoplanin. 
Conclusions: The proposed biotyping method, which is relatively fast and simple to perform, provided reproducible 
results, and may contribute to clinically effective treatment of S. mutans infections. 
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INTRODUCTION 
Streptococcus mutans is a microorganism that may be 
involved in localized chsease such as dental caries [l-51, 
systemic infections resulting from dental interventions, 
or bacteremia. In some patients with predisposing 
factors, S. mutans can lead to subacute endocarditis 
[6-81; in rare cases it has been associated with other 
severe infectious diseases [9]. Since the appearance of 
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Keyes’s study in 1960 [lo], several studies have con- 
firmed that S. mutaris is transmissible [ll-131. For these 
reasons, accurate typing is essential in order to establish 
differences in antibiotic susceptibility and provide 
effective treatment. Moreover, correct typing can shed 
light on the precise origin and incidence of different 
associated infections, including caries and bacteremia, 
thereby helping health professionals to assess the 
effectiveness of prophylactic measures in breaking the 
chain of infection. 
Various typing methods have been proposed to 
date for S. rnutans; some are based on the antigenic 
heterogeneity of the cell wall carbohydrates [14-171, 
while others detect differences in bacteriocin suscep- 
tibility [11,12,18,19]. A more complex ribotyping 
method has also been described [20]. However, 
developing an accurate biotyping procedure (i.e., one 
capable of distinguishing types within a species on the 
88 
d e  La H i g u e r a  e t  a l :  B i o t y p i n g  o f  S f r e p t o c o c c u s  m u t a n s  89 
basis of differences in biochemical behaviour) is 
especially difficult in the case of S. nzrrtms, because 
conventional assays arc unable to establish distinctions 
among the limited variety of its biochemical processes 
and distinguish corresponding biotypes [11-33]. Further 
complications arise from the fact that the term ‘S .  
mutarzr biotype’ [24-271 may be used in relation to 
subspecies included previously in the niutanr group on 
the basis of either genotype, serotype or phenotype 
[8,27-391, and the designation ‘biotype I’ is sometimes 
applied to S. rnrrturzs itself. The current trend, however, 
is to consider these bacteria not as a subtype, but rather 
as an independent species [21-23,30]. 
This paper focuses on the development and appli- 
cation of an accurate new methodology for biotyping 
S. rnirtans based on enzymatic activity; similar earlier 
studies have been reported [33]. After evaluation ofthe 
reproducibility of the results of the biotyping method, 
the coniparative susceptibility of the biotypes identified 
was tested in vitro against seven different antibiotics. 
MATERIALS AND METHODS 
In total, l h 0  strains of S. mutarts were isolated from 
clinical oral samples (saliva or supragingival plaque) 
from different subjects and identified by conventional 
methods. Cultured niicroorganisms were visualized 
after staining by Gram’s niethod and subjected to the 
following tests: arginine hydrolysis; esculin hydrolysis in 
the presence and absence of bile; mannitol, raffinose 
and inulin fermentation; and resistance to bacitracin. 
The culture media, laboratory procedures and inter- 
pretation of results have been described by Barrow 
and Feltham [31]. Identification criteria used were 
those of Maiden et a1 1231 (arginine hydrolysis negative; 
esculin hydrolysis negative in the presence of bile and 
positive in the absence of bile; mannitol, raffinose and 
inulin fermentation positive; and resistance to 2U of 
bacitrxin) . 
The 160 strains were then classified according to 
biotype obtained with the APIZYM system for enzyme 
activity (bioM6rieux; Marcy-I’Etoile, France), used 
according to the manufacturer’s instructions. However, 
indications of enzyme activity that were positive or 
negative in >80% of the strains were excluded. Tests 
were read after incubation for 1 h at 3 6 k  1°C. Enzyme 
activity, reflected by a change in the color intensity of 
the substrate, was considered positive if a reading 
between 2 and 5 was obtained; a reading of 0 was 
considered negative. The test was carried out in 
triplicate for each strain, and each set of tests was scored 
by a different observer. 
The susceptibilities of all 160 strains were then 
tested against amoxycillin, cefazolin, erythromycin, 
clindaniycin, vancomycin (Sigma, St Louis, MO, USA), 
teicoplanin (Merrell Dow, Spain) and imipenem (Merck, 
Germany) by dilution in a solid medium [33], with 
concentrations between 0.003 and 1 .0 mg/L, except 
for vancomycin and teicoplanin, which were tested at  
a range of 0.007-3.0 nig/L. The statistical significance 
of the differences in antibiotic susceptibilities of the 
biotypes was determined, based on the mean MIC 
(minimum inhibitory concentration) values with chi- 
squared tests. 
Table 1 Subdivision of 160 strains of S. rnritons into eight biotypes 
RESULTS AND CONCLUSIONS 
The new biotyping method was arrived at by excluding 
the results of enzyme activities that were positive or 
negative for >80% of the strains, leaving three enzymes 
to be considered: valine aryl amidase, acid phosphatase 
and a-galactosidase. The three API ZYM assays per- 
formed gave reproducible readings. Different conibina- 
tions of the presence or absence of these three activities 
led to the identification of eight different biotypes of S. 
mutanr, designated biotypes 1-8 (Table 1). The biotype 
that appeared most frequently (31.5%) of strains) was 
biotype 5 (valine aryl aniidase negative, acid phosphatase 
positive, a-galactosidase positive), followed by biotype 
1 (+,+,+; 17.5% of strains). The least frequent was 
biotype 3 (+,-,-), which was represented by only 
four (2.5%) strains. 
Vahne a y l  
n “;I of total ainidace Acid phosphataTe a-galactosidaqe 
B1otypc 1 + + + 28 17.5 
4 3.5 
H1otype 7 + + - 1 0  h.25 
Biotypr 3 + - - 
Biotype 4 + + -I 7 7  13.75 
B1otypr 5 - + + 50 31.25 
- 
+ - 13 7.5 Biotype 6 - 
B1otype 7 - - 
Biotype 8 - - 
+ 24 I3  
- 10 6.25 
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Table 2 Mean MIC, MIC range and MICso values (mg/mL) for selected antibiotics, associated with different biotypes 
of S.  mutans (mg/L) 
Biotype 
Antibiotic 1 2 
Amoxycillin 
MIC range 
MICso 
MIC mean 
Cefazolin 
MIC range 
MICso 
MIC mean 
Clmdamycin 
MIC range 
MIC mean 
Erythromycin 
MIC range 
MIC mean 
MICsu 
MICso 
Inllpenrm 
MIC range 
MICwi 
MIC mean 
Vancomycin 
MIC range 
MIC50 
MIC mean 
Teicoplanin 
MIC range 
MICio 
MIC mean 
0.015-0.50 
0.076 
0.03 
0.03-1 
0.06 
0.16 
0.015-1 
0.03 
0.16 
0.015-0.50 
U.06 
0.16 
0.007-0.25 
(1.03 
0.094 
0.03-1 
0.50 
0.56 
0.12-1 
0.50 
0.69 
0.015-0.50 
0.06 
0.13 
0.03-0.25 
0.06 
0.10 
0.015-0.06 
0.03 
0.033 
0.015-0.12 
0.03 
0.048 
0.015-0.50 
0.03 
0.212 
0.03-1 
0.50 
0.51 
0.12-1 
0.50 
0.474 
3 
0.034.25 
0.03 
0.033 
0.007-0.06 
0.007 
0.033 
0.01 5-0.03 
0.015 
0 . w  
n.ui 5-0.1 2 
0.015 
0.067 
0.25-0.50 
0.25 
0.375 
0.50-1 
0.50 
0.55 
0.25-0.50 
0.25 
0.375 
4 5 6 7 8 
0.015-0.03 
U.015 
0.017 
0.01 5-0.06 
0.015 
0.025 
0.015-0.06 
n.os 
0.06 
0.( 11 5-0.13 
0.03 
0.041 
0.007-0.15 
0.03 
0.083 
0.25-1 
0.50 
0.52 
0.06-1 
0.50 
0.56 
0.007-0.25 
0.03 
0.052 
0.0074.25 
0.03 
0.049 
0.007-0.50 
0.03 
0.06 
0.07-1 
0.06 
0.1 1 
0.007-0.50 
0.015 
0.077 
0.03-1 
0.50 
0.442 
0.12-1 
0.625 
0.50 
0.015-0.50 
0.03 
0.11 
0.015-0.50 
0.03 
0.19 
0.015-1 
0.03 
0.19 
0.015-0.25 
0.03 
0.069 
0.007-1 
0.015 
0.22 
0.03-1 
0.35 
0.06 
0.50-1 
0.58 
0.50 
0.0034.06 
0.015 
0.022 
0.0034.06 
0.03 
0.032 
0.0154.06 
0.03 
0.039 
0.0 154.12 
0.03 
om1 
0.003-0.03 
0.015 
0.015 
0.03-1 
0.50 
0.41 
0.12-1 
0.25 
0.375 
0.015-0.06 
0.03 
0.039 
0.015-0.06 
0.03 
0 027 
0.0154.06 
0.03 
0.03 
0.03-0.06 
0.06 
0.048 
0.0074.03 
0.015 
0.016 
0.034.50 
0.50 
0.312 
0.12-1 
0.50 
0.57 
Comparisons of the mean MICs for each anti- 
biotic, the MIC range and the MICso value (Table 2) 
showed that biotypes had different degrees of antibiotic 
susceptibility. As indicated by the mean MIC values, 
strains belonging to biotype 4 were the most susceptible 
to amoxycillin (p<O.OOl), cefazolin (p<O.OOl) and 
erythroniycin (p<O.Ol), a finding supported by the 
MICsO values. The mean MIC values showed biotype 
1 to be the least susceptible to teicoplanin (p<O.O5). 
According to the MICso values, imipenem appeared to 
be more effective against biotypes 5-8, while cefazolin 
was most effective against biotype 3 (Table 2 ) .  
An important advantage of this methodology 
for biotyping S. mutclris in comparison with other 
approaches is its reproducibility. Since the method is 
based on a commercial product, and provides clear 
positive or negative readings, the results obtained are 
remarkably consistent. Moreover, it is a relatively fast 
and simple procedure, and should thus prove valuable 
in laboratory studies involving S. mutaris. 
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